Drug Type Antibody fusion proteins |
Synonyms MEDI-5256 |
Target |
Action modulators, inhibitors |
Mechanism CD80 modulators(Cluster of differentiation 80 modulators), CD86 inhibitors(Cluster of differentiation 86 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Autoimmune Diseases | Discovery | United Kingdom | 01 Jan 2017 |